American Century Companies’s Utah Medical Products UTMD Stock Holding History

American Century Companies’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$487K	Sell	7,053 -200	-3%	-$13.3K	﹤0.01%	2586
2026 Q1	$450K	Sell	7,253 -47	-0.6%	-$2.96K	﹤0.01%	2544
2025 Q4	$409K	Sell	7,300 -878	-11%	-$50.9K	﹤0.01%	2560
2025 Q3	$515K	Sell	8,178 -577	-7%	-$34.1K	﹤0.01%	2502
2025 Q2	$498K	Buy	8,755 +65	+0.7%	+$3.54K	﹤0.01%	2526
2025 Q1	$487K	Buy	8,690 +555	+7%	+$33.3K	﹤0.01%	2519
2024 Q4	$500K	Buy	8,135 +643	+9%	+$41.6K	﹤0.01%	2505
2024 Q3	$501K	Sell	7,492 -4,429	-37%	-$301K	﹤0.01%	2476
2024 Q2	$796K	Buy	11,921 +1,830	+18%	+$125K	﹤0.01%	2264
2024 Q1	$718K	Buy	10,091 +1,694	+20%	+$127K	﹤0.01%	2289
2023 Q4	$707K	Buy	8,397 +2,427	+41%	+$201K	﹤0.01%	2220
2023 Q3	$513K	Buy	5,970 +995	+20%	+$91.8K	﹤0.01%	2259
2023 Q2	$464K	Buy	+4,975	New	+$469K	﹤0.01%	2254
2017 Q4	–	Sell	-67,094	Closed	-$4.93M	–	1373
2017 Q3	$4.93M	Sell	67,094 -93,447	-58%	-$6.72M	0.01%	854
2017 Q2	$11.6M	Sell	160,541 -9,282	-5%	-$611K	0.01%	638
2017 Q1	$10.6M	Buy	169,823 +4,435	+3%	+$279K	0.01%	655
2016 Q4	$12M	Sell	165,388 -12,562	-7%	-$817K	0.01%	627
2016 Q3	$10.6M	Sell	177,950 -10,223	-5%	-$650K	0.01%	669
2016 Q2	$11.9M	Sell	188,173 -48,784	-21%	-$3.15M	0.01%	624
2016 Q1	$14.8M	Sell	236,957 -16,851	-7%	-$994K	0.02%	567
2015 Q4	$14.9M	Buy	253,808 +358	+0.1%	+$20.3K	0.02%	556
2015 Q3	$13.7M	Sell	253,450 -11,563	-4%	-$631K	0.02%	581
2015 Q2	$15.8M	Sell	265,013 -1,943	-0.7%	-$109K	0.02%	601
2015 Q1	$16M	Sell	266,956 -37,496	-12%	-$2.2M	0.02%	592
2014 Q4	$18.3M	Buy	304,452 +9,951	+3%	+$551K	0.02%	567
2014 Q3	$14.4M	Buy	294,501 +40,542	+16%	+$2.06M	0.02%	594
2014 Q2	$13.1M	Buy	253,959 +38,882	+18%	+$2M	0.01%	643
2014 Q1	$12.4M	Buy	215,077 +4,808	+2%	+$262K	0.01%	653
2013 Q4	$12M	Sell	210,269 -2,226	-1%	-$122K	0.01%	663
2013 Q3	$12.6M	Sell	212,495 -6,328	-3%	-$345K	0.02%	631
2013 Q2	$11.9M	Buy	+218,823	New	+$10.3M	0.02%	627

Other funds holding UTMD

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

American Century Companies's UTMD Position: Q2 2026 in Review

American Century Companies reduced its Utah Medical Products (UTMD) stake by 2.8% in Q2 2026, selling an estimated $13.3K and leaving 7,053 shares worth $487K. The position accounts for ﹤0.01% of the portfolio, ranked #2586.

American Century Companies first reported a position in UTMD in Q2 2013 and has held it in 31 quarters since. The position peaked at $18.3M in Q4 2014. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

American Century Companies held 7,053 shares of Utah Medical Products worth $487K as of Q2 2026.
American Century Companies sold 200 Utah Medical Products shares in Q2 2026, an estimated $13.3K.
Utah Medical Products made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2586 holding.
American Century Companies first reported a position in Utah Medical Products in Q2 2013 and has held it in 31 quarters since.
American Century Companies's Utah Medical Products position peaked at $18.3M in Q4 2014.
114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.